Xpert MTB/RIF Ultra assay for the diagnosis of pulmonary tuberculosis in children: a multicentre comparative accuracy study
- 20 July 2018
- journal article
- research article
- Published by Elsevier BV in Journal of Infection
- Vol. 77 (4), 321-327
- https://doi.org/10.1016/j.jinf.2018.07.002
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Assessment of the novel T-cell activation marker–tuberculosis assay for diagnosis of active tuberculosis in children: a prospective proof-of-concept studyThe Lancet Infectious Diseases, 2014
- Mixed Mycobacterium tuberculosis Complex Infections and False-Negative Results for Rifampin Resistance by GeneXpert MTB/RIF Are Associated with Poor Clinical OutcomesJournal of Clinical Microbiology, 2014
- Importance of tuberculosis control to address child survivalThe Lancet, 2014
- Tuberculosis in ChildrenThe New England Journal of Medicine, 2012
- Increased and Expedited Case Detection by Xpert MTB/RIF Assay in Childhood Tuberculosis: A Prospective Cohort StudyClinical Infectious Diseases, 2012
- Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB/RIF Assay: A Prospective StudyPLoS Medicine, 2011
- Pediatric Tuberculosis: Global Overview and ChallengesClinical Infectious Diseases, 2010
- Paediatric tuberculosisThe Lancet Infectious Diseases, 2008
- A Refined Symptom-Based Approach to Diagnose Pulmonary Tuberculosis in ChildrenPEDIATRICS, 2006
- Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosisTuberculosis, 2005